Scancell to raise £15m for partner opportunities, trials, Covid vaccine
Immunotherapies developer for the treatment of cancer Scancell launched an up to £15m equity raising to support potential partnering opportunities, clinical trials and Covid-19 vaccine...
Wed, 22/07/2020 - 09:04